SB 258719

SB 258719

S656823-1ml

1ml

10mM in DMSO

-80℃储存

超低温冰袋运输

SB 258719 is a selective 5-HT 7 receptor antagonist with high affinity ( pK i =7.5) for the receptor. SB 258719 can be used for the research of cancer and neurological disease In Vitro SB 258719 (1, 3 and 10 μM; HEK 293 cells) produces a concentration-related rightward-shift of the 5-CT concentration-response curve with no signifcant alteration in the maximal response to 5-CT. MCE has not independently confirmed the accuracy of these methods. They are for reference only. In Vivo SB 258719 (5-20 mg/kg; i.p.) significantly attenuates the 5-CT-induced hypothermia. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: Male Swiss Webster mice (20-25 g). Dosage: 5-20 mg/kg Administration: I.p. Result: Significantly attenuated the 5-CT-induced hypothermia. IC50& Target:5-HT 7 Receptor 7.5 (pKi)

SB 258719 是一种选择性 5-HT 7 受体拮抗剂，对该受体具有高亲和力（pK i =7.5）。SB 258719 可用于癌症和神经系统疾病的研究。

195199-95-2(DMSO)

C18H30N2O2S

338.51 g/mol

CC1CCN(CC1)CCC(C)N(C)S(=O)(=O)C2=CC=CC(=C2)C